HMRC reveals details of R&D credits anti-fraud campaign
Earlier in 2022, HMRC announced that it was suspending payments of R&D tax credits while it investigated some claims. It has now released details of a new campaign to fight fraudulent claims. What are they?

R&D tax reliefs are a generous collection of corporation tax breaks that incentivise innovation. At the most basic level, R&D offers an enhanced deduction for qualifying expenditure, reducing. However, the relief for small and medium enterprises can be even better. Where the claimant company is loss making, part of the loss (the surrenderable loss) can be exchanged for a payable credit, equal to 14.5% of the loss surrendered. Unfortunately, the generous nature of this credit has attracted fraudsters. These “advisors” submit claims on behalf of companies, taking a share of the payable credit on a “no win, no fee” basis. As with many claims that are self-submitted, HMRC often makes a payment before asking questions, clawing back the amount (with penalties) if it is found to lack merit. Unfortunately, many fraudsters ask the company to permit HMRC to pay the money directly to them, meaning that when the demand for repayment comes through, the company is out of pocket.
As with all these types of fraud, anyone should exercise caution if approached by a third-party making claims that sound too good to be true. It may well be that there are genuine R&D costs being incurred, but it’s unlikely that the company directors would be totally unaware of these - even if they know little to nothing about R&D tax credits. HMRC is writing to companies where the claim appears to be spurious, inviting them to contact the department with further information, and reserving the right to open a criminal investigation.
Related Topics
-
Time off for fertility treatment?
A survey by Fertility Matters at Work has revealed that more than one-third of employees undergoing fertility treatment have resigned or are considering resigning because of the physical and emotional toll. Is there a right to time off for fertility treatment?
-
Was a company buyback of EIS shares tax avoidance?
Two taxpayers used the “purchase of own shares” procedure to extract gains they’d made from enterprise investment scheme (EIS) shares. HMRC said this was unfair tax avoidance, the taxpayers disagreed. What did the Upper Tribunal decide?
-
HMRC’s new compliance check service
HMRC has published a collection of videos and notes to help if you’re picked for a compliance check. Is HMRC’s new service worth a look or is it just official propaganda?